Report cover image

Global Erectile Dysfunction Treatment Market - Focused Insights 2024-2029

Publisher Arizton Advisory and Intelligence
Published Feb 06, 2024
Length 122 Pages
SKU # ARZ18485217

Description

Global Erectile Dysfunction Treatment Market - Focused Insights 2024-2029


REPORT OVERVIEW

This report offers market size & forecast data for the global erectile dysfunction treatment market. The revenue generated from the sale of drugs & devices is included in the report. This report provides a comprehensive and current market scenario of the global erectile dysfunction treatment market, including the global erectile dysfunction treatment market size, anticipated market forecast, relevant market segmentations, and industry trends.

The study considers a detailed scenario of the present global erectile dysfunction treatment market and its market dynamics for 2024−2029. It covers a detailedREPORT OVERVIEW of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent players operating in the market.

MARKET DEFINITION

Erectile dysfunction (ED) is the condition that is a persistent or recurrent inability to attain and maintain penile erection sufficient to permit satisfactory sexual activity and intercourse. ED is commonly referred to as impotence and is considered one of the most common male sexual health disorders.

KEY HIGHLIGHTS
  • The global erectile dysfunction treatment market was valued at $4,727.51 million in 2023 and registered a negative CAGR of -0.94%. The market reach is mainly attributed to the rising prevalence of erectile dysfunction and associated chronic diseases such as diabetes, benign prostate hyperplasia, prostate cancer, and CVDs, which can, in turn, pose high-risk factors for the occurrence of disease, are critical factors for the erectile dysfunction treatment market.
  • In 2023, North America and Europe dominated the market with a market share of 33.63% and 29.05%, respectively. APAC is expected to be the fastest-growing market for erectile dysfunction treatment in terms of revenue during the forecast period, with a CAGR of 2.70%.
  • Based on product, the drugs segment dominated the market over the devices segment and accounted for a market share of 79.08%, whereas the devices segment accounted for a 20.92% share. However, during the forecast period, the devices segment will likely witness the highest incremental and absolute growth of $252.58 million and 25.54%, respectively.
  • The route of administration (RoA) segment of ED drugs is sub-segmented into oral medications, penile injections, and topical drugs. Among the three sub-segments, oral drugs occupied the largest share, which is attributed to the high adoption of branded drugs. Overall, 92.57% was occupied by oral drugs, followed by penile injections at 4.70% and topical drugs at 2.73%.
  • Rising awareness, growing patient willingness to demand medical assistance for disease care and management, and the increasing presence of favorable guidelines that recommend the use of drugs and devices for the treatment of ED are expected to propel the market growth during the forecast period.
  • Bayer, Pfizer, Eli Lilly and Company, Coloplast, and Boston Scientific are some of the leading players currently dominating the global erectile dysfunction treatment market. The major players focus on strategic acquisitions and collaborations with emerging players to enter the ED treatment market and gain access to commercially launched products.
VENDORS LIST
  • Bayer
  • Pfizer
  • Coloplast
  • Eli Lilly and Company
  • Boston Scientific
  • Teva Pharma
  • Viatris
  • Dong-A Socio
  • Vivus
  • Cristalia
  • Dr.Reddy’s
  • Aurobindo
  • Seelos Therapeutics
  • Menarini Group
  • GSK plc
  • Futura Medical
  • Sanofi
  • Cipla
  • Lupin
  • Advanz Pharma
  • Sandoz
  • IX Biopharma
  • Domier Medtech
  • Zephyr Surgical Implants
  • Augusta Medical Systems
  • Metuchen Pharmaceuticals
  • SK Chemicals
  • Endo International
  • Ferring Pharmaceuticals
  • Alembic Pharmaceuticals
  • Guangzhou Pharmaceuticals
  • Launch Medical
  • Bonro Medical
  • Owen Mumford
  • Direx Group
  • Zimmer Medizin Systems
  • MTS Medical UG
  • Medispec
  • Inceler Medical
  • NOVAmedtek
  • Wikkon
  • Top Quality Group
  • Promedon
  • Timm Medical Technologies
  • Global Life Technologies
  • Urology Health Store
  • Hims
REPORT HIGHLIGHTS

PRODUCT SEGMENTATION & FORECAST
  • Product type
Drugs

Route of Administration
  • Oral Drugs
  • Penile Injections
  • Topical Drugs
Distribution Channel
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Portals
Devices

Type
  • Penile Implants
  • Vacuum Construction Devices
  • Shock Wave Therapy
  • Others
MARKET STRUCTURE
  • Market Dynamics
  • Competitive Landscape of ED Treatment Market
  • Key Vendors
  • Other Prominent Vendors
APPENDIX
  • Research Methodology
  • Abbreviations
  • About Arizton

Table of Contents

122 Pages
CHAPTER – 1: ED Treatment Market Overview
Executive Summary
Key Findings
CHAPTER – 2: ED Treatment Market
GLOBAL: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
CHAPTER – 3: ED Treatment Market Segmentation Data
GLOBAL: Projected Revenue by Product type (2022-2028; $ Millions)
▪ Drugs
Route of Administration
Oral Drugs
Penile Injections
Topical Drugs
Distribution Channels
Retail Stores
Hospital Pharmacies
Online Portals
▪ Devices
Type
Penile Implants
Vacuum Construction Devices
Shock Wave Therapy
Others
CHAPTER – 4: Key Regions Overview
North America: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
Projected Revenue of ED Treatment Market in US
Projected Revenue of ED Treatment Market in Canada
Europe: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
Projected Revenue of ED Treatment Market in UK
Projected Revenue of ED Treatment Market in Germany
Projected Revenue of ED Treatment Market in France
Projected Revenue of ED Treatment Market in Italy
Projected Revenue of ED Treatment Market in Spain
APAC: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
Projected Revenue of ED Treatment Market in Japan
Projected Revenue of ED Treatment Market in China
Projected Revenue of ED Treatment Market in India
Latin America: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
Projected Revenue of ED Treatment Market in Brazil
Projected Revenue of ED Treatment Market in Mexico
Projected Revenue of ED Treatment Market in Argentina
Middle East & Africa: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
Projected Revenue of ED Treatment Market in Saudi Arabia
Projected Revenue of ED Treatment Market in South Africa
Projected Revenue of ED Treatment Market in Turkey
CHAPTER – 5: ED Treatment Market Prospects & Opportunities
ED Treatment Market Opportunities & Trends
ED Treatment Market Drivers
ED Treatment Market Constraints
CHAPTER – 6: ED Treatment Industry Overview
ED Treatment Market - Competitive Landscape
ED Treatment Market – Key Vendor Profiles
ED Treatment Market – Other Prominent Vendors
ED Treatment Market - Key Strategic Recommendations
CHAPTER – 7: Appendix
Research Methodology
Abbreviations
About Arizton

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us